A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients.
about
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Systematic review of amifostine for the management of oral mucositis in cancer patients.Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.
P2860
A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A pilot study on feasibility a ...... l support in myeloma patients.
@en
A pilot study on feasibility a ...... l support in myeloma patients.
@nl
type
label
A pilot study on feasibility a ...... l support in myeloma patients.
@en
A pilot study on feasibility a ...... l support in myeloma patients.
@nl
prefLabel
A pilot study on feasibility a ...... l support in myeloma patients.
@en
A pilot study on feasibility a ...... l support in myeloma patients.
@nl
P2093
P2860
P1433
P1476
A pilot study on feasibility a ...... l support in myeloma patients.
@en
P2093
Jantunen E
Kuittinen T
Nousiainen T
P2860
P304
P356
10.1080/1042819021000015907
P577
2002-10-01T00:00:00Z